Business12 years ago
Novartis Seeks U.S. Approval for Two Smoker’s Cough Drugs
(Bloomberg) – Novartis AG applied for U.S. regulatory approval for two drugs to treat smoker’s cough that analysts estimate could generate an additional $1.4 billion in annual...
